First fill-finish service from iBio aims to accelerate movement to the clinic
To get biologics to market faster, iBio launches sterile fill-finish operations for preclinical and clinical biologic products.
Archives for June 4, 2019
Bluebird has lift off with first gene therapy approval
Bluebird has received EU conditional marketing approval for patients with transfusion-dependent β-thalassemia, becoming the first treatment from its pipeline to receive approval.